A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Northwestern University
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology